Recombinant monocyte-derived interleukin-1 receptor antagonist reverses inhibitory effects of interleukin-1 on Leydig cell steroidogenesis
- 31 July 1991
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 78 (3) , 205-209
- https://doi.org/10.1016/0303-7207(91)90124-b
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.Journal of Clinical Investigation, 1990
- Differential effects of recombinant interleukin-1α and β on leydig cell functionBiochemical and Biophysical Research Communications, 1990
- Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitorNature, 1990
- A monoclonal antibody to lactogenic receptors from female rat liverJournal of Endocrinology, 1989
- Native interleukin 1 inhibitorsImmunology Today, 1989
- Interleukin-1 inhibits follicle stimulating hormone-induced differentiation in rat granulosa cells in vitroBiochemical and Biophysical Research Communications, 1987
- Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s).Journal of Clinical Investigation, 1986
- Direct stimulatory effects of insulin-like growth factor-I on Leydig cell steroidogenesis in primary cultureBiochemical and Biophysical Research Communications, 1986
- Corticotropin-Releasing Activity of MonokinesScience, 1985
- Uromodulin: A Unique 85-Kilodalton Immunosuppressive Glycoprotein Isolated from Urine of Pregnant WomenScience, 1985